Shimadzu Phoretix Pro upgrade from Shimadzu Biotech

Products	Shimadzu Phoretix Pro upgrade from Shimadzu Biotech
Company	Shimadzu Biotech
Item	Shimadzu Phoretix Pro upgrade
Price
Description	The Pro upgrade for Shimadzu Phoretix 2D, Expression and Evolution supports data queries and advanced statistical tools for comparative gel analysis studies in determining differential protein expression. Data base add on component Oracle data base plug in component (Oracle version 9i release 2 client software). Supports advanced statistical tool sets for gel and spots comparison and queries (including finding significant spots, data mining using PCA, MDS or CA). Answers questions such as Which spots are similar and/or different in a single experiment? Which gels are similar between different experiments? Which spots are similar between different experiments? How reproducible are gels within a batch of experiments? Which spots need to reviewed?
Info	Shimadzu Biotech Japan/Asia Shimadzu Corporation 1 Nishinokyo Kuwabaracho Nakagyoku, Kyoto 604-8511 Japan Phone: +81-75-823-1148 Fax: +81-75-823-1364 info@shimadzu-biotech.net United States Shimadzu Biotech USA 7102 Riverwood Drive Columbia, Maryland 21046 USA Phone: 800-477-1227/410-381-1227 info@shimadzu-biotech.net England Shimadzu Biotech Wharfside Trafford Wharf Road Manchester M17 1GP England Tel +44 161 888 4414 Fax +44 161 888 4402 MALDI chris.sutton@kratos.co.uk LCMS nl@shimadzu.de For contacts in other regions please click here. Customer Service: see above Fax Number: see above Web Site: http://www.shimadzu-biotech.net

NOTE: Price information is approximate list price and actual prices may vary.

TAG: Shimadzu Phoretix Pro upgrade from Shimadzu Biotech

...CC1041 is a recombinant 177 amino acid polypeptide... human MT1-MMP. Produced by activation of a recom... coli periplasm. SPECIFIC ACTIVITY:The specific a..., where 1 U is the activity that hydrolyzes 1 mol ...

...The EC570-90 is a compact, lightweight, high curre...ts or 2500 milliamps. It is an excellent choice fo... is also ideal for all types of electroblotting ap...t to automatically end a run and wil automatically...

Anti-Interferon-beta (IFNb) Monoclonal Antibody, Unconjugated from CHEMICON

...For use in Refrigerated Vapor Trap Models RVT100, ...urce (UVS) Models UVS400, UVS400A and UVS800DDA.,...licone polymer suitable for use for temperatures r... has excellent thermal stability and does not evap...

Biology Products:

Human MMP-14 [MT1-MMP], Catalytic Domain, E. coli recombinant from CHEMICON EC570-90 Power Supply from Thermo Scientific Anti-Interferon-beta (IFNb) Monoclonal Antibody, Unconjugated from CHEMICON CryoCool Heat Transfer Fluid from Thermo Scientific

(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...

(Date:11/25/2009)... On September 11, firefighters, police officers an...rt in the World Trade Center complex. They battled...earched for survivors, tackled fires and evacuated...tained an estimated 17,000 people. And making thei...cations: frightened workers and their relatives ja...

(Date:11/25/2009)..., LA JOLLA, CAWhen you eat may be just as vital t...t the Salk Institute for Biological Studies. Their...g and waning of thousands of genes in the liverthe...d by food intake and not by the body,s circadian c...ng time determines the activity of a large number ...

Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2 First-ever blueprint of a minimal cell is more complex than expected 3 Magic box for mission impossible 2 Magic box for mission impossible 3 Feeding the clock 2 Feeding the clock 3 Oxygen Biotherapeutics Inc to Present at Investment Conferences in New York and Zurich 13695 1 Oxygen Biotherapeutics Inc to Present at Investment Conferences in New York and Zurich 13695 2 NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 1 NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 2 NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 3 NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 4 NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 5 American Brain Tumor Association Statement on the Death of U S Senator Edward M Kennedy 55380 1

[1] First-ever blueprint of a minimal cell is more complex than expected [0] Magic box for mission impossible [0] Feeding the clock

...reasing attention given to the potential of biocha... wood) to serve as a long term sink of carbon in t...nd breaks down extremely slowly, persisting in soi...estion being seriously considered by policy makers... quantities and stored in soils. This would in tur...

... in French . , Canadian, French and British re...rols the variability of blood glucose levels in pe...because high blood glucose levels in otherwise hea... and higher mortality rates. The results will be p...l Science. , The research was conducted by Dr. P...

...Texas The first year of ConocoPhillips [NYSE:COP]...a State University (ISU) has supported 26 research...orations to further diversify Americas sources of ...ocoPhillips, the third-largest integrated energy c...n to begin 14 research projects at ISU in 2007. Th...

Other Biology News:Limitations of charcoal as an effective carbon sink 2 Genetic breakthrough explains dangerously high blood glucose levels 2 Genetic breakthrough explains dangerously high blood glucose levels 3 Iowa State-ConocoPhillips collaboration advances 26 research projects in first year 2

Limitations of charcoal as an effective carbon sink Genetic breakthrough explains dangerously high blood glucose levels Iowa State-ConocoPhillips collaboration advances 26 research projects in first year

(Date:11/24/2009)... recently approved the Promega PowerPlex 16 HS Sys...nerating DNA records for the National DNA Index Sy...PRWEB) -- The FBI recently approved the Promega P...s participating in, or generating DNA records for,...tly contains more than seven million profiles and ...

(Date:11/24/2009)... 24 Shire plc (LSE: SHP,...eutical company, today,announced that it has submi...laglucerase alfa, the company,s enzyme replacement...1 Gaucher disease. This is the third marketing,app...itted, with previous,submissions in the United Sta...

(Date:11/24/2009)...November 24 Health Robotics today ...venture with a group of selected,investors. This r...under the,name Health Robotics Canada, Inc. and wi....v. Room of the Future concept, which includes the...i.v.SOFT(TM), and OMM(TM).,Health Robotics Canada ...

(Date:11/24/2009)... Cell Therapeutics, Inc. ...nt at the 21st Annual Piper Jaffray Health Care Co..., 2009, at the New York Palace Hotel. ,, CTI ...Eastern Time in Holmes 1 (4th Floor). A live audio...t www.celltherapeutics.com , and it will also be ...

Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4 Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2 Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3

[0] NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database [0] Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease [0] Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada [0] Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference